[go: up one dir, main page]

GB202404587D0 - Chemical forms - Google Patents

Chemical forms

Info

Publication number
GB202404587D0
GB202404587D0 GBGB2404587.4A GB202404587A GB202404587D0 GB 202404587 D0 GB202404587 D0 GB 202404587D0 GB 202404587 A GB202404587 A GB 202404587A GB 202404587 D0 GB202404587 D0 GB 202404587D0
Authority
GB
United Kingdom
Prior art keywords
chemical forms
chemical
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2404587.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epiendo Pharmaceuticals ehf
Original Assignee
Epiendo Pharmaceuticals ehf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epiendo Pharmaceuticals ehf filed Critical Epiendo Pharmaceuticals ehf
Priority to GBGB2404587.4A priority Critical patent/GB202404587D0/en
Publication of GB202404587D0 publication Critical patent/GB202404587D0/en
Priority to PCT/EP2025/058658 priority patent/WO2025202510A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2404587.4A 2024-03-28 2024-03-28 Chemical forms Pending GB202404587D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2404587.4A GB202404587D0 (en) 2024-03-28 2024-03-28 Chemical forms
PCT/EP2025/058658 WO2025202510A1 (en) 2024-03-28 2025-03-28 Crystalline salt forms of an azithromycin benzoate derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2404587.4A GB202404587D0 (en) 2024-03-28 2024-03-28 Chemical forms

Publications (1)

Publication Number Publication Date
GB202404587D0 true GB202404587D0 (en) 2024-05-15

Family

ID=90904801

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2404587.4A Pending GB202404587D0 (en) 2024-03-28 2024-03-28 Chemical forms

Country Status (2)

Country Link
GB (1) GB202404587D0 (en)
WO (1) WO2025202510A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070174A2 (en) 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
WO2004005310A2 (en) 2002-07-08 2004-01-15 Pliva-Istrazivacki Institut D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
WO2006087644A2 (en) 2005-01-13 2006-08-24 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Macrolides with anti-inflammatory activity
CN1837225A (en) 2005-08-23 2006-09-27 济南思创生物技术有限公司 Azithromycin derivatives and its preparation process and pharmaceutical application
WO2014166503A1 (en) 2013-04-10 2014-10-16 Probiotic Pharmaceuticals Aps Azithromycin antimicrobial derivatives with non-antibiotic pharmaceutical effect
WO2017085329A1 (en) 2015-11-19 2017-05-26 Epi-Endo Pharmaceuticals Ehf. Azithromycin derivatives with epithelial barrier enhancement properties

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070174A2 (en) 2002-02-15 2003-08-28 Sympore Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
WO2004005310A2 (en) 2002-07-08 2004-01-15 Pliva-Istrazivacki Institut D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
WO2006087644A2 (en) 2005-01-13 2006-08-24 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Macrolides with anti-inflammatory activity
CN1837225A (en) 2005-08-23 2006-09-27 济南思创生物技术有限公司 Azithromycin derivatives and its preparation process and pharmaceutical application
WO2014166503A1 (en) 2013-04-10 2014-10-16 Probiotic Pharmaceuticals Aps Azithromycin antimicrobial derivatives with non-antibiotic pharmaceutical effect
WO2017085329A1 (en) 2015-11-19 2017-05-26 Epi-Endo Pharmaceuticals Ehf. Azithromycin derivatives with epithelial barrier enhancement properties

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Remington: The Science and Practice of Pharmacy", 2000, PHILADELPHIA COLLEGE OF PHARMACY AND SCIENCE
FECIK ET AL., CURRENT OPINION IN DRUG DISCOVERY AND DEVELOPMENT, vol. 8, no. 6, 2005, pages 741 - 747
KANOH, S.RUBIN B.K.: "Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications", CLINICAL MICROBIOLOGY REVIEWS, vol. 23, no. 3, 2010, pages 590 - 615

Also Published As

Publication number Publication date
WO2025202510A1 (en) 2025-10-02

Similar Documents

Publication Publication Date Title
GB202404587D0 (en) Chemical forms
GB202509384D0 (en) Chemical compounds
GB202509390D0 (en) Chemical compounds
GB202509394D0 (en) Chemical compounds
GB202508649D0 (en) Chemical compounds
GB202508645D0 (en) Chemical compounds
CA234898S (en) Case
GB202418214D0 (en) Processes
CA240902S (en) Snowbike
CA236425S (en) Pickleball
CA236217S (en) Handwarmer
CA232701S (en) Tele-plier
CA232699S (en) Tele-plier
CA232700S (en) Tele-plier
CA230174S (en) Kettlebell
IL324931A (en) Chemical process
IL316245A (en) Chemical process
GB202509632D0 (en) Biosensor
GB202207361D0 (en) Chemical process
GB202508141D0 (en) Boardbud
GB202407810D0 (en) it
GB202407804D0 (en) It
GB202407499D0 (en) It
GB202405166D0 (en) Hyperport
GB202404712D0 (en) Dronedefencehmaairfoil